# Thirumalai Chemicals share price today (Thirumalai Chemicals Ltd, NSE: TIRUMALCHM)

> Thirumalai Chemicals share price today: ₹119.32 at the NSE close on 3 November 2026, down 57.9% in a year. Thirumalai Chemicals (NSE: TIRUMALCHM) is worth ₹1,442 crore, trades at a P/E of 50.0 and has closed between ₹114.33 and ₹264.95 over the past 52 weeks. > Thirumalai Chemicals Ltd's results are improving, and its P/E is near the top of its own history, higher than 97% of past readings. TIRUMALCHM · Speciality Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹119.32 (−57.9% in a year)
- P/E: 50.0× (higher than 97% of the last 7.6 years)
- Revenue (Jun 2026): ₹547 Cr (+21.6% on a year ago)
- Profit (Jun 2026): −₹44.0 Cr
- Operating margin: 6.0% (+12.0 points on a year ago)
- ROCE: −3%, FY26
- ROIC: −1.3%, against a 12.0% cost of capital: −13.3 points
- Profit that came in as cash: 138%, last 3 years

The main question: results are strong, and the P/E is higher than 97% of its own history. ## What is the Thirumalai Chemicals share price today? Thirumalai Chemicals Ltd's share price was ₹119.32 at the close on 3 November 2026. It has been falling for 49 weeks. That is 33.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹114 and ₹265, and at that close it sat 3% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 27 weeks running. Over the last 11 years the share price moved +588% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 5 June 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Thirumalai Chemicals this quarter? Three changes stood out: revenue grew again in the June 2026 quarter, profit grew again in the June 2026 quarter and best operating margin in 8 quarters. 1. Revenue grew again in the June 2026 quarter Revenue was ₹547 crore, +21.6% on a year earlier (₹450 crore), after 7 quarters of decline. 2. Profit grew again in the June 2026 quarter Profit was ₹-44 crore, +26.7% on a year earlier (₹-60 crore), after 4 quarters of decline. 3. Best operating margin in 8 quarters Operating margin was 6% in the June 2026 quarter, against -6% a year earlier. ## What are Thirumalai Chemicals' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Thirumalai Chemicals reported revenue of ₹547 crore, up 21.6% from ₹450 crore a year earlier, and a loss of ₹44.0 crore. ### Thirumalai Chemicals results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹547 crore | ₹450 crore | +21.6% |
| Profit | loss of ₹44.0 crore | loss of ₹60.0 crore | n/a |
| Earnings per share | ₹−3.62 | ₹−5.86 | n/a |
| Operating margin | 6.0% | −6.0% | +12.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Thirumalai Chemicals share price history? Thirumalai Chemicals closed at ₹119.32 on 3 November 2026, down 57.9% from ₹283.20 a year earlier (31 October 2025) and down 52.1% over five years. Its highest weekly close since March 2016 was ₹385.95 on 6 December 2024. ### Thirumalai Chemicals share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹120.09 | −0.6% |
| 1 month ago · 1 Oct 2026 | ₹146.26 | −18.4% |
| 6 months ago · 30 Apr 2026 | ₹204.13 | −41.5% |
| 1 year ago · 31 Oct 2025 | ₹283.20 | −57.9% |
| 3 years ago · 3 Nov 2023 | ₹196.40 | −39.2% |
| 5 years ago · 4 Nov 2021 | ₹248.90 | −52.1% |
| 10 years ago · 4 Nov 2016 | ₹86.21 | +38.4% |
| Earliest and lowest weekly close in our records · 11 Mar 2016 | ₹17.35 | +587.7% |
| Highest weekly close since March 2016 · 6 Dec 2024 | ₹385.95 | −69.1% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹264.95 | −55.0% |
| 52-week low (weekly close) · 30 Oct 2026 | ₹114.33 | +4.4% |

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (563 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on Thirumalai Chemicals? 3 Nov 2026: Thirumalai Chemicals closed at ₹119.32, down 0.6% on the week and down 18.4% on the month. Results for April to June 2026: Revenue up 21.6% on a year earlier. ## What dividend does Thirumalai Chemicals pay? Thirumalai Chemicals paid no dividend in the 12 months to 4 November 2026. The last was a dividend whose amount we could not read, ex-date 16 July 2024. ### Thirumalai Chemicals dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 16 Jul 2024 | not readable | Dividend |
| 14 Jul 2023 | ₹1.50 | Dividend |
| 19 Jul 2022 | ₹2.50 | Dividend |
| 13 Jul 2021 | ₹2.20 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 4 of 5 Of the last 5 financial years, years with an NSE dividend record

Not in its latest year. Thirumalai Chemicals Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 7 of its last 13 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is Thirumalai Chemicals on? Thirumalai Chemicals is on one of our India lists: 52 week high & low. [52 week high & low 52-week position: At 52-week low](https://www.sectoralpha.in/52-week-high-stocks-india)

## Is Thirumalai Chemicals profitable? Thirumalai Chemicals Ltd posted a net loss of ₹44.0 Cr in the Jun 2026 quarter. The full FY26 year was a loss of ₹168 Cr. That loss is 8.0% of the quarter's revenue. The same quarter a year earlier lost ₹60.0 Cr. 10 of the last 12 reported quarters were loss-making. ## How much revenue does Thirumalai Chemicals make, and is it growing? Thirumalai Chemicals Ltd reported ₹547 Cr of revenue in the Jun 2026 quarter, +21.6% on the same quarter a year earlier. Over 10 years it has grown 6.3% a year on average. The last full year, FY26, came in at ₹1,736 Cr. The last four reported quarters add to ₹1,832 Cr. FY26 revenue was ₹1,736 Cr, −15.3% on the year before. Recent pace: the last four quarters grew −4.8% on average, against 6.3% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −5.8%, against −7.0% a year over the last 8 quarters (stabilising). ## How much of every ₹100 of sales does Thirumalai Chemicals keep? Thirumalai Chemicals Ltd's operating margin was 6.0% in the Jun 2026 quarter, 12.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between −2.0% and 22.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +11.9 percentage points on the year while gross margin changed +7.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Thirumalai Chemicals' profit turning into cash? Over the last 3 years, 138% of Thirumalai Chemicals Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 its operations used ₹131 Cr of cash, against −₹168 Cr of profit. After ₹1,254 Cr of spending on assets, free cash was −₹1,385 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 138% of profit came in as cash: the cash cycle got 40 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 13.7× depreciation over three years. The next section checks what that spending is building. ## Where does Thirumalai Chemicals' cash go? Thirumalai Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 14 days in FY26, up from −26 days in FY21. It spent ₹2,904 Cr on assets over the last 3 years. Customers take 41 days to pay, and stock sits for 50 days on average. At FY26 sales of ₹1,736 Cr, each day of that cycle ties up about ₹4.8 Cr, so roughly ₹67.0 Cr is tied up in the business at any time. FY26: customers took 41 days to pay and stock sat for 50 days, about 1.6 months of sales sitting as stock, for a full cycle of 14 days, longer than FY21's −26. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 50 days. Customers pay about 41 days after that. Suppliers are paid at 77 days. Together that makes the 14-day cycle. Spending on assets: ₹2,904 Cr over the last 3 years, against ₹212 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹2,518 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Thirumalai Chemicals' P/E ratio, and how does it compare with its own history? Thirumalai Chemicals Ltd's P/E is 50.0×, near the high end of its own history: higher than 97% of past readings. Its usual P/E (the middle reading) is 10.7×, over 7.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Where the price move came from: over 5 years the price moved −13.7% a year; about −24.8% a year came from earnings growth and about +11.1 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Thirumalai Chemicals business getting better or worse? Thirumalai Chemicals Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Thirumalai Chemicals earn on its capital? Thirumalai Chemicals Ltd earned a ROCE of −3% in FY26. Its return on capital used (ROIC) is 13.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −9.7% net margin and 0.37× asset turnover (sales divided by assets). Why the return is what it is (FY26): a −9.7% net margin × 0.37× asset turnover × 3.03× leverage (assets divided by equity) ≈ −10.9% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: −1.3% − 12.0% = −13.3 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −1.3% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at −3.3%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Thirumalai Chemicals have too much debt? Thirumalai Chemicals Ltd has total debt of ₹2,175 Cr against shareholder equity of ₹1,564 Cr as of Jun 2026, so its debt is 1.39× its equity. Year by year, that ratio went from 0.15 in FY22 to 1.39 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Thirumalai Chemicals shareholding pattern? Domestic institutions raised their stake in Thirumalai Chemicals Ltd by 5.4 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 6.7% of the company. Promoters moved −4.8 points over the same period, to 37.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: +5.4 points over 8 quarters, to 6.7%; Promoters: −4.8 points over 8 quarters, to 37.1%; Foreign institutions: −1.5 points over 8 quarters, to 1.4%. Why the owners changed: foreign institutions moved −1.5 points and domestic institutions +5.4 points over 8 quarters, while promoters moved −4.8 points. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is Thirumalai Chemicals from balance-sheet trouble? For Thirumalai Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Thirumalai Chemicals rank in its industry? 27.2 out of 100, rank 30 of 30 in Speciality Chemicals, with 68% of the evidence available. Thirumalai Chemicals Ltd scores 27.2 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 30. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 16.2 + 0.7 + 10 + 0.3 = 27.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Thirumalai Chemicals compared with? Thirumalai Chemicals ranks 30 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 27.2 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 80.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 15.9/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 15.9 + 19.7 + 13.9 = 80.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.3/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.3 + 6.6 + 12.5 = 64.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.8/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.8 + 10.8 + 10.8 = 64 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.4/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.4 + 10 + 10.9 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.7/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.7 + 11.3 + 11.4 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.8/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.8 + 9.7 + 14.8 = 59.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.5/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.5 + 5.7 + 19.5 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.7/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.7 + 16.1 + 7.8 = 55.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.2 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.9 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 53.0 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative
15. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.8 out of 100 Growth Capital Valuation Relative
16. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.5 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 51.1 out of 100 Growth Capital Valuation Relative
18. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 47.9 out of 100 Growth Capital Valuation Relative
19. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
20. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.8 out of 100 Growth Capital Valuation Relative
21. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
22. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
23. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 42.5 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.5 out of 100 Growth Capital Valuation Relative
26. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.4 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. Thirumalai Chemicals Ltd this page TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.2/35 · Revenue -5.8% · Profit -36.9% · Operating margin change 12 points · 65% evidence Capital efficiency 0.7/25 · ROCE -3.1% · Operating margin 6% · 100% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 0.3/20 · Lead over its industry -45.6% · Lead over NIFTY 500 -35.7% · 1 year -59.6% · 100% evidence · 1 of 12 weeks ahead Exact sum: 16.2 + 0.7 + 10 + 0.3 = 27.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Thirumalai Chemicals in size? Thirumalai Chemicals is the 19th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Panama Petrochem, Innovassynth Technologies (India) and Paushak. Just below it: Platinum Industries, Vikram Thermo (India) and Sunshield Chemicals. ### Speciality Chemicals companies close in size

1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) ₹2,726 crore
2. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) ₹1,468 crore
3. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) ₹1,450 crore
4. Thirumalai Chemicals Ltd ₹1,378 crore
5. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) ₹1,215 crore
6. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) ₹1,129 crore
7. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) ₹882 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [Balmer Lawrie Investment Ltd](https://www.sectoralpha.in/stocks/balmer-lawrie-investment-ltd) ₹1,386 crore · Finance & Investments - Others
2. [Alicon Castalloy Ltd](https://www.sectoralpha.in/stocks/alicon-castalloy-ltd) ₹1,378 crore · Castings, Forgings & Fastners
3. Thirumalai Chemicals Ltd ₹1,378 crore
4. [Anlon Healthcare Ltd](https://www.sectoralpha.in/stocks/anlon-healthcare-ltd) ₹1,376 crore · Pharmaceuticals Bulk Drugs & Formulation
5. [Bhartiya International Ltd](https://www.sectoralpha.in/stocks/bhartiya-international-ltd) ₹1,365 crore · Textiles

## What else do people ask about Thirumalai Chemicals? ### What is Thirumalai Chemicals's share price today? Thirumalai Chemicals Ltd's share price is ₹119.32, −57.9% over the past year. The whole company is worth ₹1,442 Cr on the market. In the last 52 weeks it traded between ₹114 to ₹265; today it is 3% of the way up from the low, 33.4% below its 200-day average (as of 3 November 2026). ### What were Thirumalai Chemicals's latest quarterly results? Thirumalai Chemicals Ltd reported revenue of ₹547 Cr and a net loss of ₹44.0 Cr for the Jun 2026 quarter. Earnings per share were −₹3.62. The operating margin was 6.0%, 12.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Thirumalai Chemicals's market cap? Thirumalai Chemicals Ltd's market capitalisation is ₹1,442 Cr at a share price of ₹119.32. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Thirumalai Chemicals performing? Thirumalai Chemicals Ltd's share price has been falling for 49 weeks. Over the past 13 weeks it has done worse than the NIFTY 500, for 27 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Thirumalai Chemicals's share price go up? This page does not forecast Thirumalai Chemicals Ltd's share price. What it shows instead: the share price is ₹119.32, and it has been falling for 49 weeks. Its P/E of 50.0× is higher than 97% of its own last 8 years (as of 3 November 2026). ### Who owns Thirumalai Chemicals? Promoters own 37.1% of Thirumalai Chemicals Ltd, foreign institutions 1.4%, domestic institutions 6.7% and the public 54.8% (latest quarter). The biggest change over the last two years: Domestic institutions raised their stake by 5.4 percentage points over 8 quarters (as of 3 November 2026). ### Where is Thirumalai Chemicals in its business cycle? Thirumalai Chemicals Ltd's FY26 operating margin was −2.0%, against a 13-year range of −2.0% to 22.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 6.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Thirumalai Chemicals story? The main question: results are strong, and the P/E is higher than 97% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Thirumalai Chemicals a stock worth studying right now? What the numbers show: Thirumalai Chemicals Ltd's results are improving, and its P/E is near the top of its own history, higher than 97% of past readings. The main open question: whether earnings grow enough to match the multiple. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- 52 week high & low: https://www.sectoralpha.in/52-week-high-stocks-india

This is research, not advice. We’re not SEBI-registered.